Human fortilin is a molecular target of dihydroartemisinin

FEBS Lett. 2008 Apr 2;582(7):1055-60. doi: 10.1016/j.febslet.2008.02.055. Epub 2008 Mar 4.

Abstract

Dehydroartemisinin (DHA) is an effective anti-malaria agent. Fortilin is an anti-apoptotic molecule overexpressed in many human cancers. Here, we show that DHA binds human fortilin, increases the ubiquitination of fortilin, shortens fortilin's half-life in a proteasome-dependent fashion, and reduces cellular levels of fortilin in varieties of cells. DHA induced DNA fragmentation in U2OS cells in a fortilin-dependent manner. The fortilin-knocked-down cells were less susceptible--and fortilin-overexpressing cells more susceptible--to DHA than were wild-type cells, suggesting that apoptotic effects of DHA are-at least partly-conferred through fortilin. Together, these data suggest that fortilin is a molecular target of DHA. DHA and its derivative may prove to be viable anti-cancer agents in fortilin-overexpressing cancers.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Apoptosis
  • Artemisinins / chemistry
  • Artemisinins / pharmacology*
  • Biomarkers, Tumor / genetics
  • Biomarkers, Tumor / metabolism*
  • Cell Line
  • DNA Fragmentation
  • Half-Life
  • Humans
  • Proteasome Endopeptidase Complex / metabolism
  • RNA, Messenger / metabolism
  • Sesquiterpenes / chemistry
  • Sesquiterpenes / pharmacology*
  • Tumor Protein, Translationally-Controlled 1
  • Ubiquitin / metabolism

Substances

  • Antineoplastic Agents
  • Artemisinins
  • Biomarkers, Tumor
  • RNA, Messenger
  • Sesquiterpenes
  • Tumor Protein, Translationally-Controlled 1
  • Ubiquitin
  • artenimol
  • Proteasome Endopeptidase Complex